I Got Sick, Lost Everything, and Found This Instead

At 28 years old, he was placed in a nursing home. He couldn't walk. He could barely eat or swallow. Three years earlier, a doctor had told him to get used to a wheelchair for life. He didn't. This is the story of a man whose early career in Congress was interrupted by an MS diagnosis that arrived disguised as vision loss — what followed was a decade of relapses, emergency rooms, and experimental treatments. What saved him wasn't willpower alone. It was access to newly approved disease-modifying therapies that happened to become available at exactly the right moments in his disease progression. Those drugs gave him back his life: a career at FEMA on 9/11, a wife, four sons, and twenty years of remission. Forced into early retirement when his MS progressed, he picked up a paintbrush. No training, no background, no prior interest. A whole new language for telling stories — and a platform for advocating on behalf of the patients who will depend on the drugs that exist only if the economic incentives to develop them remain intact. Key topics: • Living with relapsing-remitting multiple sclerosis and its unpredictable progression • How disease-modifying therapies have transformed MS outcomes over 30 years • The policy threat to drug innovation: IRA pricing and international reference pricing • Why patient access to treatment and pharmaceutical innovation are inseparable • One man's journey through loss, reinvention, and the power of hope Built for: MS patients and caregivers, pharmaceutical policy advocates, patient advocacy organizations, healthcare policy professionals, and anyone committed to preserving biomedical innovation. #MultipleSclerosis #MS #MSAwareness #DrugInnovation #PatientAdvocacy #HealthcarePolicy #MSResearch #PharmaceuticalPolicy --- RaffertyWeiss Media is an award-winning, full-service video production agency based in Bethesda, MD. 📧 Visit RaffertyWeiss Media to explore video production for health advocacy, patient education, and nonprofit storytelling: https://www.raffertyweiss.com